Selected research
Industry Research
Metformin Hydrochloride and Vildagliptin Tablets Industry Research Report 2026
Market perspective
The global Metformin Hydrochloride and Vildagliptin Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Metformin Hydrochloride and Vildagliptin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Metformin Hydrochloride and Vildagliptin Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Metformin Hydrochloride and Vildagliptin Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Metformin Hydrochloride and Vildagliptin Tablets include Zhejiang Nuode Pharmaceutical, Yangtze River Pharmaceutical, Qilu Pharmaceutical, Novartis and Nanjing Yoko Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Metformin Hydrochloride and Vildagliptin Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Metformin Hydrochloride and Vildagliptin Tablets Market by Company
Zhejiang Nuode Pharmaceutical
Yangtze River Pharmaceutical
Qilu Pharmaceutical
Novartis
Nanjing Yoko Pharmaceutical
Metformin Hydrochloride and Vildagliptin Tablets Segment by Type
Type Ⅱ
Type Ⅲ
Metformin Hydrochloride and Vildagliptin Tablets Segment by Application
Hospital
Clinic
Others
Metformin Hydrochloride and Vildagliptin Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metformin Hydrochloride and Vildagliptin Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Metformin Hydrochloride and Vildagliptin Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metformin Hydrochloride and Vildagliptin Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Metformin Hydrochloride and Vildagliptin Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Metformin Hydrochloride and Vildagliptin Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Metformin Hydrochloride and Vildagliptin Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Type Ⅱ
- Type Ⅲ
Applications
- Hospital
- Clinic
- Others
Companies covered
- Zhejiang Nuode Pharmaceutical
- Yangtze River Pharmaceutical
- Qilu Pharmaceutical
- Novartis
- Nanjing Yoko Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Metformin Hydrochloride and Vildagliptin Tablets Market Size (2021-2032)
- 2.2.2 Global Metformin Hydrochloride and Vildagliptin Tablets Sales (2021-2032)
- 2.2.3 Global Metformin Hydrochloride and Vildagliptin Tablets Market Average Price (2021-2032)
- 2.3 Metformin Hydrochloride and Vildagliptin Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Type Ⅱ
- 2.3.3 Type Ⅲ
- 2.4 Metformin Hydrochloride and Vildagliptin Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Metformin Hydrochloride and Vildagliptin Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Metformin Hydrochloride and Vildagliptin Tablets Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Metformin Hydrochloride and Vildagliptin Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Metformin Hydrochloride and Vildagliptin Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Metformin Hydrochloride and Vildagliptin Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Metformin Hydrochloride and Vildagliptin Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Metformin Hydrochloride and Vildagliptin Tablets, Product Type & Application
- 3.8 Global Manufacturers of Metformin Hydrochloride and Vildagliptin Tablets, Established Date
- 3.9 Global Metformin Hydrochloride and Vildagliptin Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhejiang Nuode Pharmaceutical
- 4.1.1 Zhejiang Nuode Pharmaceutical Company Information
- 4.1.2 Zhejiang Nuode Pharmaceutical Business Overview
- 4.1.3 Zhejiang Nuode Pharmaceutical Metformin Hydrochloride and Vildagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhejiang Nuode Pharmaceutical Metformin Hydrochloride and Vildagliptin Tablets Product Portfolio
- 4.1.5 Zhejiang Nuode Pharmaceutical Recent Developments
- 4.2 Yangtze River Pharmaceutical
- 4.2.1 Yangtze River Pharmaceutical Company Information
- 4.2.2 Yangtze River Pharmaceutical Business Overview
- 4.2.3 Yangtze River Pharmaceutical Metformin Hydrochloride and Vildagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Yangtze River Pharmaceutical Metformin Hydrochloride and Vildagliptin Tablets Product Portfolio
- 4.2.5 Yangtze River Pharmaceutical Recent Developments
- 4.3 Qilu Pharmaceutical
- 4.3.1 Qilu Pharmaceutical Company Information
- 4.3.2 Qilu Pharmaceutical Business Overview
- 4.3.3 Qilu Pharmaceutical Metformin Hydrochloride and Vildagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Qilu Pharmaceutical Metformin Hydrochloride and Vildagliptin Tablets Product Portfolio
- 4.3.5 Qilu Pharmaceutical Recent Developments
- 4.4 Novartis
- 4.4.1 Novartis Company Information
- 4.4.2 Novartis Business Overview
- 4.4.3 Novartis Metformin Hydrochloride and Vildagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Novartis Metformin Hydrochloride and Vildagliptin Tablets Product Portfolio
- 4.4.5 Novartis Recent Developments
- 4.5 Nanjing Yoko Pharmaceutical
- 4.5.1 Nanjing Yoko Pharmaceutical Company Information
- 4.5.2 Nanjing Yoko Pharmaceutical Business Overview
- 4.5.3 Nanjing Yoko Pharmaceutical Metformin Hydrochloride and Vildagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Nanjing Yoko Pharmaceutical Metformin Hydrochloride and Vildagliptin Tablets Product Portfolio
- 4.5.5 Nanjing Yoko Pharmaceutical Recent Developments
5 Global Metformin Hydrochloride and Vildagliptin Tablets Market Scenario by Region
- 5.1 Global Metformin Hydrochloride and Vildagliptin Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Metformin Hydrochloride and Vildagliptin Tablets Sales by Region: 2021-2032
- 5.2.1 Global Metformin Hydrochloride and Vildagliptin Tablets Sales by Region: 2021-2026
- 5.2.2 Global Metformin Hydrochloride and Vildagliptin Tablets Sales by Region: 2027-2032
- 5.3 Global Metformin Hydrochloride and Vildagliptin Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Metformin Hydrochloride and Vildagliptin Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Metformin Hydrochloride and Vildagliptin Tablets Revenue by Region: 2027-2032
- 5.4 North America Metformin Hydrochloride and Vildagliptin Tablets Market Facts & Figures by Country
- 5.4.1 North America Metformin Hydrochloride and Vildagliptin Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Metformin Hydrochloride and Vildagliptin Tablets Sales by Country (2021-2032)
- 5.4.3 North America Metformin Hydrochloride and Vildagliptin Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Metformin Hydrochloride and Vildagliptin Tablets Market Facts & Figures by Country
- 5.5.1 Europe Metformin Hydrochloride and Vildagliptin Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Metformin Hydrochloride and Vildagliptin Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Metformin Hydrochloride and Vildagliptin Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Metformin Hydrochloride and Vildagliptin Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Metformin Hydrochloride and Vildagliptin Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Metformin Hydrochloride and Vildagliptin Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Metformin Hydrochloride and Vildagliptin Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Metformin Hydrochloride and Vildagliptin Tablets Market Facts & Figures by Country
- 5.7.1 South America Metformin Hydrochloride and Vildagliptin Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Metformin Hydrochloride and Vildagliptin Tablets Sales by Country (2021-2032)
- 5.7.3 South America Metformin Hydrochloride and Vildagliptin Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Metformin Hydrochloride and Vildagliptin Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Metformin Hydrochloride and Vildagliptin Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Metformin Hydrochloride and Vildagliptin Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Metformin Hydrochloride and Vildagliptin Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Metformin Hydrochloride and Vildagliptin Tablets Sales by Type (2021-2032)
- 6.1.1 Global Metformin Hydrochloride and Vildagliptin Tablets Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Metformin Hydrochloride and Vildagliptin Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Metformin Hydrochloride and Vildagliptin Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Metformin Hydrochloride and Vildagliptin Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Metformin Hydrochloride and Vildagliptin Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Metformin Hydrochloride and Vildagliptin Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Metformin Hydrochloride and Vildagliptin Tablets Sales by Application (2021-2032)
- 7.1.1 Global Metformin Hydrochloride and Vildagliptin Tablets Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Metformin Hydrochloride and Vildagliptin Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Metformin Hydrochloride and Vildagliptin Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Metformin Hydrochloride and Vildagliptin Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Metformin Hydrochloride and Vildagliptin Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Metformin Hydrochloride and Vildagliptin Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Metformin Hydrochloride and Vildagliptin Tablets Value Chain Analysis
- 8.1.1 Metformin Hydrochloride and Vildagliptin Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Metformin Hydrochloride and Vildagliptin Tablets Production Mode & Process
- 8.2 Metformin Hydrochloride and Vildagliptin Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Metformin Hydrochloride and Vildagliptin Tablets Distributors
- 8.2.3 Metformin Hydrochloride and Vildagliptin Tablets Customers
9 Global Metformin Hydrochloride and Vildagliptin Tablets Analyzing Market Dynamics
- 9.1 Metformin Hydrochloride and Vildagliptin Tablets Industry Trends
- 9.2 Metformin Hydrochloride and Vildagliptin Tablets Industry Drivers
- 9.3 Metformin Hydrochloride and Vildagliptin Tablets Industry Opportunities and Challenges
- 9.4 Metformin Hydrochloride and Vildagliptin Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst